These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15137034)

  • 1. The design, synthesis and evaluation of affinity ligands for prion proteins.
    Soto Renou EN; Gupta G; Young DS; Dear DV; Lowe CR
    J Mol Recognit; 2004; 17(3):248-61. PubMed ID: 15137034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper has differential effect on prion protein with polymorphism of position 129.
    Wong BS; Clive C; Haswell SJ; Williamson RA; Burton DR; Gambetti P; Sy MS; Jones IM; Brown DR
    Biochem Biophys Res Commun; 2000 Mar; 269(3):726-31. PubMed ID: 10720484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating the conformation of prion protein through ligand binding.
    Yamamoto N; Kuwata K
    J Phys Chem B; 2009 Oct; 113(39):12853-6. PubMed ID: 19725511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion].
    Ishikawa T
    Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lock-and-key motif as a concept for designing affinity adsorbents for protein purification.
    Platis D; Sotriffer CA; Clonis Y; Labrou NE
    J Chromatogr A; 2006 Sep; 1128(1-2):138-51. PubMed ID: 16860333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a class of diketopiperazines as antiprion compounds.
    Bolognesi ML; Ai Tran HN; Staderini M; Monaco A; López-Cobeñas A; Bongarzone S; Biarnés X; López-Alvarado P; Cabezas N; Caramelli M; Carloni P; Menéndez JC; Legname G
    ChemMedChem; 2010 Aug; 5(8):1324-34. PubMed ID: 20540064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen/deuterium exchange mass spectrometric analysis of conformational changes accompanying the assembly of the yeast prion Ure2p into protein fibrils.
    Redeker V; Halgand F; Le Caer JP; Bousset L; Laprévote O; Melki R
    J Mol Biol; 2007 Jun; 369(4):1113-25. PubMed ID: 17482207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intriguing nucleic-acid-binding features of mammalian prion protein.
    Silva JL; Lima LM; Foguel D; Cordeiro Y
    Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity chromatography on immobilized "biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand.
    Teng SF; Sproule K; Husain A; Lowe CR
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):1-15. PubMed ID: 10798290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of bovine prion protein to heparin: a fluorescence polarization study.
    Andrievskaia O; Potetinova Z; Balachandran A; Nielsen K
    Arch Biochem Biophys; 2007 Apr; 460(1):10-6. PubMed ID: 17353004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
    Kenward AG; Bartolotti LJ; Burns CS
    Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites.
    King DJ; Safar JG; Legname G; Prusiner SB
    J Mol Biol; 2007 Jun; 369(4):1001-14. PubMed ID: 17481659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) ion binding to cellular prion protein.
    Zidar J; Pirc ET; Hodoscek M; Bukovec P
    J Chem Inf Model; 2008 Feb; 48(2):283-7. PubMed ID: 18247504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
    Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
    Davies P; Marken F; Salter S; Brown DR
    Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
    Boshuizen RS; Langeveld JP; Salmona M; Williams A; Meloen RH; Langedijk JP
    Anal Biochem; 2004 Oct; 333(2):372-80. PubMed ID: 15450815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.